HQY has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HQY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-04-25), HealthEquity's share price is $78.7411. HealthEquity's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jan. 2024 was $2.26. Hence, HealthEquity's Price-to-Free-Cash-Flow Ratio for today is 34.80.
The historical rank and industry rank for HealthEquity's Price-to-Free-Cash-Flow or its related term are showing as below:
During the past 12 years, HealthEquity's highest Price-to-Free-Cash-Flow Ratio was 1400.20. The lowest was 30.50. And the median was 76.18.
HealthEquity's Free Cash Flow per Share for the three months ended in Jan. 2024 was $0.75. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $2.26.
During the past 12 months, the average Free Cash Flow per Share Growth Rate of HealthEquity was 506.70% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 26.50% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -10.80% per year.
During the past 12 years, HealthEquity's highest 3-Year average Free Cash Flow per Share Growth Rate was 80.40% per year. The lowest was -68.80% per year. And the median was 12.70% per year.
The historical data trend for HealthEquity's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthEquity Annual Data | |||||||||||||||||||||
Trend | Jan15 | Jan16 | Jan17 | Jan18 | Jan19 | Jan20 | Jan21 | Jan22 | Jan23 | Jan24 | |||||||||||
Price-to-Free-Cash-Flow | Get a 7-Day Free Trial | 71.88 | 74.66 | 1,137.02 | 163.14 | 33.40 |
HealthEquity Quarterly Data | ||||||||||||||||||||
Apr19 | Jul19 | Oct19 | Jan20 | Apr20 | Jul20 | Oct20 | Jan21 | Apr21 | Jul21 | Oct21 | Jan22 | Apr22 | Jul22 | Oct22 | Jan23 | Apr23 | Jul23 | Oct23 | Jan24 | |
Price-to-Free-Cash-Flow | Get a 7-Day Free Trial | 163.14 | 37.48 | 34.40 | 35.02 | 33.40 |
For the Health Information Services subindustry, HealthEquity's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, HealthEquity's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where HealthEquity's Price-to-Free-Cash-Flow falls into.
HealthEquity's Price-to-Free-Cash-Flow ratio for today is calculated as
Price-to-Free-Cash-Flow Ratio | = | Share Price | / | Free Cash Flow per Share (TTM) |
= | 78.7411 | / | 2.263 | |
= | 34.80 |
HealthEquity's Share Price of today is $78.7411.
HealthEquity's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.26.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Price-to-Free-Cash-Flow Ratio | = | Market Cap | / | Free Cash Flow |
HealthEquity (NAS:HQY) Price-to-Free-Cash-Flow Explanation
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Thank you for viewing the detailed overview of HealthEquity's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Delano Ladd | officer: Executive VP, GC & Corp. Secy. | 15W. SCENIC POINTE DR., SUITE 100, DRAPER UT 84020 |
Ian Sacks | director | TOWERBROOK CAP., PARK AVENUE TOWER, 65 E 55TH ST., 27TH FLOOR, NEW YORK NY 10022 |
Elimelech Rosner | officer: EVP, Chief Technology Officer | 5196 BELMORE COURT, SUWANEE GA 30024 |
Stephen Neeleman | director, officer: Founder and Vice Chairman | 15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020 |
Tyson D. Murdock | officer: EVP & CFO | 2275 S. 2200 E., SALT LAKE CITY UT 84109 |
Jon Kessler | director, officer: President and CEO | 15 W. SCENIC POINTE DR., STE. 100, DRAPER UT 84020 |
Frank Corvino | director | GREENWICH HOSPITAL, 5 PERRYRIDGE ROAD, GREENWICH CT 06830 |
Larry L Trittschuh | officer: EVP Chief Security Officer | 1051 RUNNYMEDE ROAD, OAKWOOD OH 45419 |
James M Lucania | officer: EVP & CFO | 101 WOLF DRIVE, THOROFARE NJ 08086 |
Gayle Furgurson Wellborn | director | 123 TORRENCE CHAPEL ROAD, MOORESVILLE NC 28117 |
Debra Charlotte Mccowan | director | 1436 CABRILLO AVENUE, BURLINGAME CA 94010 |
Paul Black | director | 400 WOOD ROAD, BRAINTREE MA 02184 |
Edward Bloomberg | officer: Chief Operating Officer | 13207 WINDSOR STREET, LEAWOOD KS 66209 |
Rajesh Natarajan | director | 7500 DALLAS PARKWAY, SUITE 700, PLANO TX 75024 |
Evelyn S Dilsaver | director | C/O LONGS DRUG STORES CORPORATION, 141 NORTH CIVIC DRIVE, WALNUT CREEK CA 94596 |
From GuruFocus
By Value_Insider Value_Insider • 11-01-2022
By GuruFocus Research • 12-22-2023
By Marketwired • 09-19-2023
By Marketwired • 08-14-2023
By Marketwired • 08-08-2023
By PurpleRose PurpleRose • 08-08-2022
By Ds*** Ds*** • 09-01-2022
By Value_Insider Value_Insider • 12-13-2022
By PurpleRose PurpleRose • 07-15-2022
By Value_Insider Value_Insider • 11-15-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.